Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.66 USD | -0.18% | +5.40% | -44.13% |
01/05 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
01/05 | Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.13% | 466M | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Editas Medicine Says Sickle Cell Disease Therapy Showed Positive Safety, Efficacy Data in Clinical Trial